40
Participants
Start Date
July 8, 2025
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
Patiromer 8400 MG [Veltassa]
Randomized patients will receive one 8.4 g packet of patiromer per day or one identical packet containing a placebo. To minimize the possibility of interference with gastrointestinal absorption of other orally administered medications, administration of patiromer will be separated by at least 3 hours from other oral medicinal products. Throughout the whole study period, the study drug will be administered every day in the morning.
Placebo
Randomized patients will receive one packet of placebo identical to that of patiromer. Following the same treatment sequence of patiromer, administration of the placebo will be separated by at least 3 hours from any other oral medicinal products. As for patiromer, the placebo will be administered every day in the morning.
RECRUITING
Nephrology Unit, ASST Papa Giovanni XXIII, Bergamo
Mario Negri Institute for Pharmacological Research
OTHER